The Global Janus Kinase Inhibitor Market Continues To Grow Owing To the Increased Demand from Healthcare Organizations to Treat Conditions Such As SLE and Increasing Investment in the R&D Sector

 

Janus Kinase Inhibitor Market

Janus Kinase Inhibitor is one of the most promising newly-developed anti-neurotransmitter drugs that is developed for treating diseases that involve the neuroendocrine system, the pituitary gland, and other glands and organ systems. The drug specifically affects the production of neuropeptide Y, a chemical neurotransmitter in the brain that is involved in regulating mood, anxiety, and sexuality.

Janus Kinase Inhibitor works by inhibiting the action of one or perhaps more of the family of neurotransmitters, thereby interfering with the neurotransmitter signaling pathway. Neurotransmitters are chemical messages sent from one nerve cell to another, which typically include dopamine, epinephrine, norepinephrine, and serotonin. When these neurotransmitters are broken down by Janus Kinase Inhibitor, the brain does not receive the neurotransmitter message that it normally needs for normal functioning. This is believed to underlie the depression, anxiety, and mood disorders that many of these neurotransmitter inhibitors have been shown to relieve. One of the proposed mechanisms for how the Janus Kinase Inhibitor work is by preventing the entry of calcium into the synaptic vesicles of the affected neurons, which is a necessary step in the formation of long-term memories.

Market Dynamics                                               

The main factor driving the Janus Kinase Inhibitor market is the rapid inclination towards industrial researches related to immune response and signaling. For instance, in Jun2 2018, U.S. Food and Drug Administration (FDA) approved OLUMIANT (baricitinib), developed by Eli Lilly and Company. It is an oral medicine for treating rheumatoid arthritis in adults. Moreover, key manufacturers and several research organizations are also focusing on the research and development of better Janus Kinase Inhibitor drugs.

However, the high cost associated with the drugs and the treatments is the main restraining factor hindering the growth of the Janus Kinase Inhibitor market.

This market is distributed in five regions that include North America, Asia-Pacific, Europe, Africa, and the Middle East, and Latin America. Among these, North America is estimated to hold a significant share of the Janus Kinase Inhibitor market owing to a high prevalence of systemic lupus erythematosus (SLE) in the region. For instance, according to the Lupus Foundation of America, 1.5 million U.S. residents suffer from SLE, and among them, 90% are mostly women. The Janus Kinase Inhibitor market in Asia-Pacific is expected to witness a significant rise owing to the increased awareness related to health conditions such as SLE in the region, backed by favorable government health policies and adoption of advanced technology in the healthcare sectors.

Competitive Analysis

Key players operating in the global Janus kinase inhibitor market include Incyte Corporation, CTI BioPharma Corp., Sierra Oncology, Inc., Gilead Sciences Inc., Novartis International AG, Baxter International Inc., Pfizer Inc.,  Astellas Pharma Inc., and Eli Lilly and Company.

In February 2021, SHR0302, a Janus kinase type 1 (JAK1) inhibitor developed by Reistone Biopharma Co. Ltd. cleared the Phase 2 Clinical Study.


Location: India

Comments

Post a Comment

Popular posts from this blog

Fitness Equipment Market is doing warm-ups to pull growth-rich opportunities from the growing obesity rates accompanied by the sedentary lifestyles

Image
  Fitness equipment is any mechanical device or equipment used in sport or exercise to improve the physical performance or strength of that activity by providing either adjustable or constant levels of force, either of dynamic nature that is immediately available to exert (such as running) or of a static type that requires adjustments (such as a bicycle). Some common types of equipment are treadmills, elliptical machines, step machines, exercise bicycles, recumbent bikes, treadmill monitors, rowing machines, and many more. Fitness equipment is used in gyms and private home fitness facilities as well as public parks and recreational facilities. Fitness equipment for the home is designed to provide low-impact aerobic workouts. Some items are available for rent or sale on the Internet. Rowing machines and exercise bicycles can give an all-over body workout, while Schwinn exercise bicycles can be used to target specific muscles. Fitness equipment for home gyms can be classified into card
Read more

The market for ureteral stents would benefit from the rising prevalence of urological diseases

Image
  A ureteral stent is a slender adaptable cylinder embedded straightforwardly into the ureter to forestall or cure block of the urinary entry from the ureter. The length of these stents utilized for grown-up quiet's reaches somewhere in the range of 30 and 24 inches. Furthermore, various distances across or sizes of stents are accessible, to suit distinctive ureter sizes. This permits treatment choices to be customized to the person, just as to the degree of obstacle. Urinary stents are made of either metal silicone or plastic. They are set straightforwardly into the bladder through the urethra valve. Ureteral stents can either be made percutaneously, through medical procedure or by methods for an outpatient strategy. Contingent upon the sort of ureter that is influenced, the technique can be either a solitary needle or numerous needles. The developing commonness of urological illnesses around the world is driving the development of the ureteral stents market . Development in t
Read more

The North America Vision Care Market Is Driven by the Increasing Prevalence of Eye Diseases in this Region

Image
  Vision care refers to the prevention and treatment of various eye conditions or eye diseases, such as refractive errors, age-related macular degeneration, cataract, glaucoma, etc. Vision care helps prevent or minimize the threat to eyes or visual integrity. Therefore, in North America, demand for vision care is has increased due the increasing prevalence of eye diseases, driving the North America vision care market growth. According to the Centers for Disease Control and Prevention (CDC), cataract affects around 24.4 million Americans (aged 40 and older) or around one in every six people in this age group. Vision care is important because 80% of what we perceive comes through our sense of sight. By protecting the eyes, people can reduce the odds of vision loss or blindness while also staying on top of any developing eye diseases such as glaucoma and cataracts. Vision care products used for restoration of eye sights include contact lenses, reading glasses, frames, Rx-Lenses, non Rx-
Read more